| Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 207 | 2017 |
| The potential role of dopamine D3 receptor neurotransmission in cognition S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ... European Neuropsychopharmacology 23 (8), 799-813, 2013 | 204 | 2013 |
| Treating negative symptoms in schizophrenia: an update G Remington, G Foussias, G Fervaha, O Agid, H Takeuchi, J Lee, M Hahn Current treatment options in psychiatry 3, 133-150, 2016 | 203 | 2016 |
| An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022 | 161 | 2022 |
| Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia H Takeuchi, C Siu, G Remington, G Fervaha, RB Zipursky, G Foussias, ... Neuropsychopharmacology 44 (6), 1036-1042, 2019 | 159 | 2019 |
| Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis H Uchida, H Takeuchi, A Graff-Guerrero, T Suzuki, K Watanabe, ... Journal of clinical psychopharmacology 31 (4), 497-502, 2011 | 159 | 2011 |
| Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms H Takeuchi, T Suzuki, H Uchida, K Watanabe, M Mimura Schizophrenia research 134 (2-3), 219-225, 2012 | 145 | 2012 |
| Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study H Takeuchi, T Suzuki, G Remington, RR Bies, T Abe, A Graff-Guerrero, ... Schizophrenia Bulletin 39 (5), 993-998, 2013 | 136 | 2013 |
| Language barriers and access to psychiatric care: a systematic review A Ohtani, T Suzuki, H Takeuchi, H Uchida Psychiatric Services 66 (8), 798-805, 2015 | 127 | 2015 |
| Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis H Uchida, T Suzuki, H Takeuchi, T Arenovich, DC Mamo Schizophrenia bulletin 37 (4), 788-799, 2011 | 124 | 2011 |
| Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ... Schizophrenia research 164 (1-3), 164-175, 2015 | 103 | 2015 |
| Predicting dopamine D2 receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis H Uchida, H Takeuchi, A Graff-Guerrero, T Suzuki, K Watanabe, ... Journal of clinical psychopharmacology 31 (3), 318-325, 2011 | 100 | 2011 |
| Antipsychotic polypharmacy and corrected QT interval: a systematic review H Takeuchi, T Suzuki, G Remington, H Uchida The Canadian Journal of Psychiatry 60 (5), 215-222, 2015 | 98 | 2015 |
| Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use G Remington, J Lee, O Agid, H Takeuchi, G Foussias, M Hahn, G Fervaha, ... Expert opinion on drug safety 15 (9), 1193-1203, 2016 | 83 | 2016 |
| The evolution of antipsychotic switch and polypharmacy in natural practice—a longitudinal perspective C Tsutsumi, H Uchida, T Suzuki, K Watanabe, H Takeuchi, S Nakajima, ... Schizophrenia research 130 (1-3), 40-46, 2011 | 79 | 2011 |
| Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey H Tani, H Uchida, T Suzuki, Y Shibuya, H Shimanuki, K Watanabe, R Den, ... BMC Oral Health 12, 1-6, 2012 | 77 | 2012 |
| Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis H Yaegashi, S Kirino, G Remington, F Misawa, H Takeuchi CNS drugs 34, 579-598, 2020 | 67 | 2020 |
| Life satisfaction and happiness among young adults with schizophrenia G Fervaha, O Agid, H Takeuchi, G Foussias, G Remington Psychiatry Research 242, 174-179, 2016 | 67 | 2016 |
| Antipsychotics and amotivation G Fervaha, H Takeuchi, J Lee, G Foussias, PJ Fletcher, O Agid, ... Neuropsychopharmacology 40 (6), 1539-1548, 2015 | 67 | 2015 |
| Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia T Suzuki, H Uchida, H Takeuchi, S Nakajima, K Nomura, A Tanabe, ... Human Psychopharmacology: Clinical and Experimental 24 (8), 628-638, 2009 | 66 | 2009 |
